SUMMARY -Cardiovascular diseases are the world's leading cause of death. Human physiologic activities and state during illness are under the control of circadian rhythm. Th e aim of the study was to determine the potential association of chronotype and daytime sleepiness with susceptibility to myocardial infarction. We conducted a case-control study on 200 patients hospitalized due to myocardial infarction and 200 healthy controls. Systematic information on the past and present medical history was obtained from all participants. Chronotype was assessed using the Morningness-Eveningness Questionnaire (MEQ), and daytime sleepiness was assessed by the Epworth Sleepiness Scale (ESS). Th e mean age of the study population was 64±13 years, and 54.5% were male. Th ere was no signifi cant diff erence in MEQ (58.88±6.52 vs. 58.46±7.78, p=0.601) or ESS (5 (interquartile range, IQR 4-7.5) vs. 6 (IQR 3-8), p=0.912) score between patients and controls. Nevertheless, we found statistically signifi cant diff erences related to risk factors for cardiovascular diseases, such as hypertension, dyslipidemia, and diabetes mellitus. However, there was no association of MEQ and ESS score with myocardial infarction in the study population.
Introduction
According to the World Health Organization, cardiovascular diseases (CVD) are the world's leading cause of death, accounting for 17.5 million deaths annually, of which ischemic heart disease caused 7.3 million deaths 1 . In Croatia, myocardial infarction (MI) is the third leading cause of death 2 . Although numerous studies on MI have been conducted, its etiology remains largely unknown 3 . Circadian rhythms are associated with many cardiovascular parameters 4 . Human physiologic activities and state during illness are under the control of circadian rhythm, which controls physiology at multiple levels, from gene expression to complex behaviors [5] [6] [7] . Th e eff ect of circadian rhythm on acute MI has been the subject of considerable scientifi c interest 8 . Sleep is one of the main requirements for the normal psychophysical functioning of every person 9 , especially needed in situations of physical and psychological stress. Sleep disorders are common phenomena in modern society with the prevalence rising to 11.9%, and they are associated with vascular outcomes such as MI 10 . Humans can be categorized into diff erent circadian phenotypes (chronotypes) depending on their preferred time of sleep and wakefulness 11 . One study showed that daytime sleepiness was an independent risk factor for cardiovascular events 12 , but there are no studies regarding chronotype as a risk factor for MI or CVD. Th ere is little research done regarding this issue, and there are only a few studies in the population of MI patients 13, 14 . Some cardiovascular risk factors, such as diabetes and hypertension, are associated with chronotype and sleep 13 , while diabetes, smoking, and reinfarction can modify the circadian rhythm 15 . Circadian clocks are altered in animal models with increased CVD risk, including aging, diet-induced obesity, diabetes, hypertension, simulated shift work, and ischemia 16 . Circadian desynchrony of the body from its environment, either through rotating shift-work schedules or genetic alteration, augments the development of CVD 16 . Th erefore, we hypothesized that MI might be associated with chronotype and daytime sleepiness in humans. To test the hypothesis, we performed a casecontrol study on a population of MI patients in comparison with a control population.
Materials and Methods

Participants
Patients with MI were hospitalized at the Department of Cardiovascular Diseases and Intensive Care, Osijek University Hospital Centre in Osijek, Croatia.
Th ygesen et al. defi ned MI by the presence of at least two of the following: typical increase of biochemical marker of myocardial necrosis -cardiac troponin T (above the 99 th percentile), ischemic chest pain symptoms lasting for more than 30 minutes, and electrocardiography (ECG) changes indicative of ischemia (ST-segment elevation or depression) 17 . Patients were excluded from this study if they did not meet the above criteria or if they had a percutaneous coronary intervention or coronary artery bypass grafting.
Th e control group consisted of 200 healthy sexand age-matched participants, whose medical documentation did not show any history of CVD. Th ey were selected by their own primary care physician. We excluded any patient relatives from the control group because, according to large studies, approximately 50% of the chronotype features are estimated to be heritable 18, 19 . 
Questionnaires
Systematic information on the past and present medical history was collected from all participants. Th e questionnaire included questions on age, education, employment, caff eine consumption, history of smoking, family history of MI, former CVD, hypertension, dyslipidemia, respiratory diseases, diabetes mellitus types 1 and 2, thyroid gland diseases, kidney and liver diseases. Hypertension was defi ned as a history of hypertension of more than two years requiring initiation of antihypertensive therapy prescribed by primary physicians. Dyslipidemia was defi ned as having a reported history of elevated fasting concentration of total cholesterol or triglycerides. Diabetes mellitus was defi ned as reported diabetes or receiving oral hypoglycemic agent treatment or insulin treatment. Positive family history of CVD was defi ned as evidence of coronary artery disease in fi rst-degree relatives before 60 years of age, such as a history of MI, coronary artery bypass surgery, and angina pectoris. Former CVD was defi ned as a reported history of angina pectoris, MI, arrhythmia or stroke in the patient group. All given information was checked in the patient medical records.
Chronotype was assessed with the MorningnessEveningness Questionnaire (MEQ) in the hospital after the patient medical condition had been stabilized 20, 21 . MEQ classifi es participants scored between 59 and 86 as morning types, those scored between 42 and 58 as intermediate types, and those scored 16-41 as evening types. Th e scores were added, and the sum was converted into a three-point MEQ scale.
Daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS, contact information and permission to use: Mapi Research Trust, Lyon, France) 22, 23 . Participants were asked how often would they say they doze off or fall asleep in the following situations: sitting and reading, watching TV, sitting inactive in a public place, as a passenger in a car for an hour without break, lying down to rest in the afternoon, sitting and talking to someone, sitting quietly after lunch without alcohol, and in a car while stopped for a few minutes in the traffi c. For each of these eight situations, responses were recorded on a scale of 0 to 3 and coded as follows: 0 = never doze, 1 = slight chance, 2 = moderate chance, and 3 = high chance. Th e ESS score for each participant was simply the sum of the results for their eight responses (range 0-24), and the sum was converted into four types of daytime sleepiness.
Data analyses
Data were expressed as absolute frequencies with percentages, means with standard deviations (SD), and medians with interquartile range (IQR), where appropriate. Mann-Whitney U test was used to test diff erences between disease status and chronotype and daytime sleepiness. Th e analyses were performed separately for women and men because of the sex diff erence in cardiovascular morbidity and mortality and the diff erential self-reporting of sleep habits between women and men supported in previous studies 12 . Risk factors for CVD such as smoking, hypertension and dyslipidemia were compared with the MEQ and ESS scores by Pearson χ 2 -tests. Th e level of statistical signifi cance was set at p<0.05, and all signifi cant values were assessed after Bonferroni correction for the number of independent hypotheses tested. All analyses were performed using Statistica 12 (StatSoft, Inc., version 12, Tulsa, OK, USA) system for Windows.
Results
Demographic and general characteristics of the study sample are summarized in Table 1 .
Th e mean age of the study population was 64±13 years, and 54.5% were males.
In female patients and controls, a signifi cant diff erence was found in smoking and age (χ 2 =103.9, df=76, p=0.018 and χ 2 =129.8, df=74, respectively; p<0.001), while there was no signifi cant diff erence in smoking and age in male patients and controls (χ 2 =89.9, df=88, p=0.421 and χ 2 =89.5, df=88; p=0.435). Th e prevalence of cardiovascular risk factors among study participants is shown in Table 2 .
Between-group comparisons revealed that three chronotype groups and three ESS groups were similar according to age and gender. Half (50.5%) of the MI patients were of intermediate chronotype, while only a small part (0.5%) was of evening chronotype (Table 3) . Th ere was no signifi cant diff erence between patients and controls in daytime sleepiness (5 (IQR, 4-7.5) vs. 6 (IQR, 3-8), Z=0.11; p=0.912) ( Table 4) . Th ere was no statistically signifi cant diff erence in the ESS and MEQ scores between genders in patient and control groups. 
Discussion
In this case-control study, we found no association of chronotype and daytime sleepiness with MI, but we 12, 19, 24, 25 . We examined gender diff erences in the ESS and MEQ scores in the two groups, but we found none. Th is may have been due to the high mean age (>60) of our study population; according to Roenneberg et al. and Roenneberg and Merrow 26, 27 , after around 50 years of age, genderrelated diff erences in chronotype and CVD disappear [26] [27] [28] . It is considered that estrogens have a cardioprotective eff ect, and older adults go to sleep earlier than they used to go while they were younger, so they become earlier chronotype [26] [27] [28] . Th e ESS score was included to assess daytime sleepiness because sleep is an important modulator of cardiovascular and metabolic function 14 . Ahmed et al. 29 report that the ESS score is a good predictive factor for obstructive sleep apnea, which has a very high incidence in MI patients, so that it might be associated with MI. Our results, with no association of daytime sleepiness with MI, are in concordance with the results of Boden-Albala et al. 14 . Some studies showed an association between diabetes, hypertension, smoking, and reinfarction with chronotype and daytime sleepiness 13, 15 . Our fi nding of a diff erence in intermediate chronotype and diabetes mellitus type 2 in female patients is important because of the infl uence of metabolic syndromes on circadian rhythm and CVD. Diabetes type 2 increases the risk of CVD 13, 30 . Metabolic syndromes, diabetes mellitus type 2, dyslipidemia, and smoking were not associated with ESS score in our study and the study by Whitney et al. 31 , whereas other studies found an association 15, 32 . We found no association of evening chronotype with hypertension and diabetes mellitus type 2 in our study, in contrast to the study by Merikanto et al. 13 . Many studies showed that evening chronotype was associated with lower HDL cholesterol levels, metabolic syndrome, and higher stress hormones 13, [33] [34] [35] . Th us, evening chronotype is associated with metabolic risk factors that predispose to CVD, which is in accordance with our results.
An association of ESS with stroke and vascular events was found in the NOMAS study 14 . Although daytime sleepiness and chronotype for itself are not signifi cant risk factors for MI, ESS and MEQ are associated with risk factors for CVD. Desynchronization of the circadian system may contribute to metabolic syndrome and complications such as dyslipidemia, glucose intolerance, hypertension, diabetes mellitus type 2, and CVD 36 . A limitation of the study was the use of questionnaires because all answers given by the participants referring to chronotype and daytime sleepiness might be a subjective evaluation of the circadian rhythms. Th e assessment could be more objective if taken by digital recording sleep duration and quality. Another limitation of the study was its sample size. To obtain suffi cient power, larger and multicenter studies are needed. For participants in control groups, there is a risk of developing some cardiovascular events, such as angina pectoris or MI.
We found no evidence for chronotype and daytime sleepiness to be directly associated with MI, while some cardiovascular risk factors such as age, dyslipidemia, diabetes mellitus, and smoking might be associated with MEQ or ESS. It is hard to predict developing MI or some other major cardiovascular events based just on the MEQ or ESS score.
